Risk of haemorrhagic and ischaemic stroke in patients with cancer: A nationwide follow-up study from Sweden

2012 ◽  
Vol 48 (12) ◽  
pp. 1875-1883 ◽  
Author(s):  
Bengt Zöller ◽  
Jianguang Ji ◽  
Jan Sundquist ◽  
Kristina Sundquist
Keyword(s):  
Ischaemic Stroke ◽  
Patients With Cancer ◽  
Follow Up Study

Cognitive variables associated with depressive and anxiety symptoms in patients with cancer: A five‐year follow‐up study

2021 ◽  
Author(s):  
Amador Priede ◽  
Noelia Rodríguez‐Pérez ◽  
Fernando Hoyuela ◽  
Patricia Cordero‐Andrés ◽  
Olga Umaran‐Alfageme ◽  
...  
Keyword(s):  
Anxiety Symptoms ◽  
Cognitive Variables ◽  
Patients With Cancer ◽  
Follow Up Study

scholarly journals Influenza in patients with cancer after 2009 pandemic AH1N1: An 8‐year follow‐up study in Mexico

2019 ◽  
Vol 14 (2) ◽  
pp. 196-203 ◽  
Author(s):  
Diego Ángeles‐Sistac ◽  
Alexandra Martin‐Onraet ◽  
Patricia Cornejo‐Juárez ◽  
Patricia Volkow ◽  
Carolina Pérez‐Jimenez ◽  
...  
Keyword(s):  
Patients With Cancer ◽  
Follow Up Study

Mechanically and electrically elicited median nerve SEPs in ischaemic stroke — 1 year follow-up study

1993 ◽  
Vol 87 (2) ◽  
pp. S135
Author(s):  
N. Goljar ◽  
T.S. Prevec ◽  
T. Žgur
Keyword(s):  
Ischaemic Stroke ◽  
Median Nerve ◽  
Follow Up Study

scholarly journals Reply to Course and predictors of posttraumatic stress disorder in a cohort of psychologically distressed patients with cancer: A 4-year follow-up study-methodological and statistical issues

Cancer ◽  
2018 ◽  
Vol 124 (11) ◽  
pp. 2457-2457 ◽  
Author(s):  
Caryn Mei Hsien Chan ◽  
Chong Guan Ng ◽  
Aishah Taib ◽  
Lei Hum Wee ◽  
Edward Krupat ◽  
...  
Keyword(s):  
Posttraumatic Stress Disorder ◽  
Posttraumatic Stress ◽  
Stress Disorder ◽  
Patients With Cancer ◽  
Follow Up Study ◽  
Statistical Issues

Analysis of the efficacy and safety of naloxegol administered to patients with cancer and opioid-induced constipation with laxative-inadequate response: A real-world 12 months of follow-up study.

2020 ◽  
Vol 38 (15_suppl) ◽  
pp. e24155-e24155
Author(s):  
Manuel Cobo Dols ◽  
Carmen Beato ◽  
Luis Cabezon-Gutierrez ◽  
Rodolfo Chicas Sett ◽  
Isabel Blancas ◽  
...  
Keyword(s):  
Real World ◽  
Pain Control ◽  
Adverse Reactions ◽  
Response To Treatment ◽  
Inadequate Response ◽  
Efficacy And Safety ◽  
Real World Data ◽  
Patients With Cancer ◽  
Follow Up Study

e24155 Background: Naloxegol is a peripherally acting, µ-opioid receptor antagonist for treatment of opioid-induced constipation (OIC). The main objective of this study was to analyze the efficacy and safety of naloxegol in patients with cancer in a real-world 12-month follow-up study. Methods: An observational prospective study was conducted in 16 Spanish centers. Patients older than 18 years, with active oncological disease who were under treatment with opioids for pain control and Karnofsky ≥ 50 were selected. OIC with inadequate response to treatment with laxative (s) was the main diagnostic. All the patients received treatment with naloxegol according to clinical criteria. Efficacy was measured by the response rate and symptoms evolution measured by means of PAC-SYM questionnaire. Intensity of pain was measured by a 0-10-point visual analogue scale (VAS). Intent to treat last observation carried forward was applied. Results: A total of 126 patients were included in the study. About 58.7% were men, with a mean age of 61.5 years (34-89). Lung cancer was observed in 35.7%, breast cancer in 16.7%, 10.3% digestive cancer and 8.7% had prostate cancer. About 67.5% had metastases. Naloxegol at doses of 25 mg/day was administered to 88.1% and with concomitant laxatives in 48.4%. At 12 months, 77.8% of the patients were responders to naloxegol treatment: 78.6% at doses of 12.5 mg/day, and 78.4% with 25 mg/day. Furthermore, response was observed in 78.5% of patients without concomitant laxative treatment and 77% of patients with any concomitant laxative. PAC-SYM total score and all the dimensions improved from baseline (p < 0.0001). VAS pain intensity was reduced and controlled from baseline onwards (Baseline-12 months: 4.6 to 3.6, p < 0.001). A total of 28 adverse reactions mainly gastrointestinal were observed in 15.1% of the patients (19/126), 75% (21) mild, 17.9% (5) moderate and 7.1% (2) severe. Most adverse reactions (67.9%) were observed the first 15 days of treatment with naloxegol. Conclusions: The results of this first real-world-data study in patients with cancer confirm the long-term efficacy of naloxegol for the treatment of OIC in this group of patients. Naloxegol is safe and well tolerated in patients with cancer while maintaining pain control.

Exercise and quality of life after first-ever ischaemic stroke: a two-year follow-up study

2017 ◽  
Vol 128 (6) ◽  
pp. 540-548 ◽  
Author(s):  
Lisha Hou ◽  
Xudong Du ◽  
Longmei Chen ◽  
Jijie Li ◽  
Peijing Yan ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Ischaemic Stroke ◽  
Follow Up Study

scholarly journals Risk of ischaemic stroke in patients with migraine: a longitudinal follow-up study using a national sample cohort in South Korea

BMJ Open ◽  
2019 ◽  
Vol 9 (4) ◽  
pp. e027701 ◽  
Author(s):  
Sang-Yeon Lee ◽  
Jae-Sung Lim ◽  
Dong Jun Oh ◽  
Il Gyu Kong ◽  
Hyo Geun Choi
Keyword(s):  
South Korea ◽  
Ischaemic Stroke ◽  
Statistical Significance ◽  
Young Patients ◽  
Haemorrhagic Stroke ◽  
Control Group ◽  
Follow Up Study ◽  
Increased Risk ◽  
Migraine Group

ObjectiveAccumulating evidence has supported the association between migraine and stroke, but the causative association remains unclear. We aimed to investigate the risks of different types of stroke in patients with migraine.DesignA longitudinal follow-up study.SettingData collected from a national cohort between 2002 and 2013 by the South Korea Health Insurance Review and Assessment.ParticipantsWe extracted the data from patients with migraine (n=41 585) and 1:4 matched controls (n=1 66 340) and analysed the occurrence of ischaemic and haemorrhagic strokes. The migraine group included participants treated for migraine (International Classification of Disease-10 (ICD-10): G43)≥2 times. Haemorrhagic stroke (I60-I62) and ischaemic stroke (I63) were determined based on the admission histories. The crude and adjusted HRs were calculated using Cox proportional hazard models, and the 95% CI were determined. Subgroup analyses stratified by age and sex were also performed.ResultsHigher rates of ischaemic stroke were observed in the migraine group (2.3% [964/41,585]) than in the control group (2.0% [3294/166 340], P<0.001). The adjusted HR for ischaemic stroke was 1.18 (95% CI=1.10 to 1.26) in the migraine group (P<0.001). Compared with control subjects, participants who reported migraine with aura and migraine without aura had increased adjusted HRs of 1.44 (95% CI=1.09 to 1.89) and 1.15 (95% CI=1.06 to 1.24), respectively, for ischaemic stroke, but no increased risk of haemorrhagic stroke. In our subgroup analysis, a strong association between migraine and ischaemic stroke was observed in young patients, specifically young women. The contribution of migraine to the occurrence of ischaemic stroke was also observed in middle-aged women and old women (each P<0.05). The risk of haemorrhagic stroke did not reach statistical significance in any age group.ConclusionMigraine is associated with an increased risk of ischaemic stroke, but not haemorrhagic stroke.

Diffusion-weighted imaging in ischaemic stroke: a follow-up study

2000 ◽  
Vol 42 (3) ◽  
pp. 184-191 ◽  
Author(s):  
J. Weber ◽  
H. P. Mattle ◽  
O. Heid ◽  
L. Remonda ◽  
G. Schroth
Keyword(s):  
Ischaemic Stroke ◽  
Diffusion Weighted Imaging ◽  
Follow Up Study ◽  
Diffusion Weighted

Ischaemic Stroke in Young People: A Prospective and Long-Term Follow-Up Study

2003 ◽  
Vol 15 (1-2) ◽  
pp. 121-128 ◽  
Author(s):  
Rossella Musolino ◽  
Paolino La Spina ◽  
Antonio Granata ◽  
Giuseppe Gallitto ◽  
Nestore Leggiadro ◽  
...  
Keyword(s):  
Young People ◽  
Ischaemic Stroke ◽  
Follow Up Study ◽  
Long Term Follow Up ◽  
Stroke In Young

Risk of coronary heart disease in patients with cancer: A nationwide follow-up study from Sweden

2012 ◽  
Vol 48 (1) ◽  
pp. 121-128 ◽  
Author(s):  
Bengt Zöller ◽  
Jianguang Ji ◽  
Jan Sundquist ◽  
Kristina Sundquist
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Patients With Cancer ◽  
Follow Up Study
Sign in / Sign up

Export Citation Format

Share Document